 Karen Wilson
Concepts (306)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tobacco Smoke Pollution | 24 | 2021 | 217 | 9.780 |
Why?
| | Cotinine | 10 | 2021 | 69 | 3.620 |
Why?
| | Smoking Cessation | 10 | 2023 | 374 | 2.910 |
Why?
| | Hospitalization | 22 | 2023 | 1751 | 1.890 |
Why?
| | Environmental Exposure | 5 | 2020 | 372 | 1.730 |
Why?
| | Electronic Nicotine Delivery Systems | 8 | 2023 | 71 | 1.630 |
Why?
| | Bronchiolitis | 5 | 2020 | 81 | 1.490 |
Why?
| | Housing | 4 | 2021 | 114 | 1.480 |
Why?
| | Marijuana Smoking | 3 | 2020 | 224 | 1.470 |
Why?
| | Hospitals, Pediatric | 16 | 2022 | 480 | 1.470 |
Why?
| | Pediatrics | 8 | 2021 | 979 | 1.440 |
Why?
| | Smoke-Free Policy | 3 | 2021 | 13 | 1.420 |
Why?
| | Tobacco Products | 7 | 2024 | 98 | 1.420 |
Why?
| | Parents | 9 | 2021 | 1186 | 1.410 |
Why?
| | Smoke | 4 | 2020 | 123 | 1.370 |
Why?
| | Hospital Medicine | 4 | 2017 | 82 | 1.240 |
Why?
| | Tobacco Smoking | 3 | 2021 | 21 | 1.230 |
Why?
| | Child | 52 | 2022 | 18412 | 1.220 |
Why?
| | Hospitalists | 5 | 2021 | 174 | 1.150 |
Why?
| | Vaping | 4 | 2023 | 45 | 1.150 |
Why?
| | Child, Preschool | 35 | 2021 | 9114 | 1.060 |
Why?
| | Biomarkers | 5 | 2020 | 3408 | 1.050 |
Why?
| | Cannabis | 4 | 2021 | 384 | 1.010 |
Why?
| | Smoking | 11 | 2023 | 1381 | 1.000 |
Why?
| | Asthma | 9 | 2022 | 2029 | 0.980 |
Why?
| | Adolescent | 45 | 2024 | 17841 | 0.910 |
Why?
| | Dronabinol | 3 | 2020 | 118 | 0.900 |
Why?
| | Infant | 25 | 2022 | 7961 | 0.900 |
Why?
| | Influenza, Human | 4 | 2017 | 546 | 0.820 |
Why?
| | Rhabdomyolysis | 1 | 2022 | 16 | 0.820 |
Why?
| | Croup | 2 | 2022 | 22 | 0.810 |
Why?
| | Humans | 87 | 2024 | 114662 | 0.800 |
Why?
| | Length of Stay | 9 | 2022 | 962 | 0.800 |
Why?
| | Child, Hospitalized | 2 | 2020 | 38 | 0.790 |
Why?
| | Male | 57 | 2024 | 55583 | 0.740 |
Why?
| | Seizures | 3 | 2018 | 340 | 0.720 |
Why?
| | Female | 57 | 2024 | 59493 | 0.680 |
Why?
| | Cesarean Section | 1 | 2020 | 169 | 0.640 |
Why?
| | Conversion Disorder | 1 | 2018 | 9 | 0.610 |
Why?
| | Cytokines | 2 | 2018 | 1840 | 0.610 |
Why?
| | Patient Admission | 3 | 2018 | 176 | 0.600 |
Why?
| | United States | 25 | 2024 | 12181 | 0.580 |
Why?
| | Air Pollution, Indoor | 1 | 2018 | 108 | 0.570 |
Why?
| | Counseling | 4 | 2022 | 342 | 0.560 |
Why?
| | Retrospective Studies | 24 | 2022 | 12546 | 0.560 |
Why?
| | Medical Marijuana | 1 | 2018 | 97 | 0.550 |
Why?
| | Child Health | 1 | 2018 | 127 | 0.530 |
Why?
| | Medical Audit | 1 | 2016 | 75 | 0.530 |
Why?
| | Systemic Inflammatory Response Syndrome | 3 | 2021 | 72 | 0.520 |
Why?
| | Personal Satisfaction | 1 | 2017 | 182 | 0.510 |
Why?
| | Acute Kidney Injury | 1 | 2022 | 637 | 0.510 |
Why?
| | Dexamethasone | 5 | 2022 | 317 | 0.500 |
Why?
| | Biomedical Research | 3 | 2017 | 585 | 0.500 |
Why?
| | Encephalitis | 1 | 2017 | 127 | 0.490 |
Why?
| | Influenza Vaccines | 2 | 2017 | 497 | 0.490 |
Why?
| | Information Dissemination | 1 | 2017 | 186 | 0.480 |
Why?
| | Social Media | 1 | 2017 | 131 | 0.460 |
Why?
| | Epilepsy | 1 | 2018 | 278 | 0.460 |
Why?
| | Colorado | 7 | 2020 | 4099 | 0.460 |
Why?
| | Pneumonia | 3 | 2019 | 567 | 0.450 |
Why?
| | Inpatients | 5 | 2022 | 380 | 0.450 |
Why?
| | Smoking Prevention | 3 | 2021 | 157 | 0.450 |
Why?
| | Health Policy | 1 | 2017 | 334 | 0.440 |
Why?
| | Complementary Therapies | 2 | 2006 | 72 | 0.440 |
Why?
| | Leukocytosis | 1 | 2013 | 34 | 0.430 |
Why?
| | Nonprescription Drugs | 3 | 2011 | 68 | 0.430 |
Why?
| | Adolescent Health Services | 3 | 2002 | 68 | 0.420 |
Why?
| | Medication Errors | 2 | 2011 | 88 | 0.420 |
Why?
| | Infant, Newborn | 11 | 2021 | 5045 | 0.410 |
Why?
| | Internet | 1 | 2017 | 596 | 0.410 |
Why?
| | Patient Readmission | 6 | 2018 | 610 | 0.400 |
Why?
| | Abdominal Pain | 1 | 2013 | 135 | 0.400 |
Why?
| | Tobacco Use | 2 | 2024 | 60 | 0.400 |
Why?
| | Peer Review, Research | 1 | 2012 | 34 | 0.400 |
Why?
| | Hypertension | 1 | 2020 | 1056 | 0.390 |
Why?
| | Vaccination | 2 | 2017 | 1204 | 0.390 |
Why?
| | Carotid Intima-Media Thickness | 1 | 2011 | 65 | 0.380 |
Why?
| | Young Adult | 12 | 2024 | 10466 | 0.370 |
Why?
| | Health Services Research | 1 | 2013 | 371 | 0.360 |
Why?
| | New York City | 2 | 2021 | 70 | 0.360 |
Why?
| | Cohort Studies | 11 | 2023 | 4895 | 0.350 |
Why?
| | Micronutrients | 1 | 2011 | 78 | 0.350 |
Why?
| | Carotid Arteries | 1 | 2011 | 180 | 0.350 |
Why?
| | Child Welfare | 1 | 2011 | 192 | 0.340 |
Why?
| | Surveys and Questionnaires | 8 | 2023 | 4622 | 0.330 |
Why?
| | Inflammation Mediators | 1 | 2012 | 477 | 0.330 |
Why?
| | Cross-Sectional Studies | 9 | 2021 | 4408 | 0.320 |
Why?
| | Tonsillectomy | 3 | 2015 | 72 | 0.320 |
Why?
| | Adult | 16 | 2024 | 30544 | 0.300 |
Why?
| | Quality Improvement | 2 | 2022 | 950 | 0.290 |
Why?
| | Drug-Related Side Effects and Adverse Reactions | 1 | 2010 | 238 | 0.290 |
Why?
| | Sex Factors | 3 | 2020 | 1715 | 0.290 |
Why?
| | Antioxidants | 1 | 2011 | 530 | 0.290 |
Why?
| | Patient Discharge | 3 | 2018 | 772 | 0.290 |
Why?
| | Health Knowledge, Attitudes, Practice | 3 | 2011 | 1183 | 0.280 |
Why?
| | Adolescent Behavior | 3 | 2006 | 489 | 0.270 |
Why?
| | Residence Characteristics | 2 | 2022 | 275 | 0.270 |
Why?
| | Prenatal Exposure Delayed Effects | 1 | 2011 | 452 | 0.260 |
Why?
| | Electroencephalography | 2 | 2018 | 362 | 0.250 |
Why?
| | Dietary Supplements | 2 | 2006 | 460 | 0.250 |
Why?
| | Pandemics | 6 | 2023 | 1317 | 0.230 |
Why?
| | Severity of Illness Index | 4 | 2016 | 2538 | 0.230 |
Why?
| | Universities | 3 | 2023 | 340 | 0.230 |
Why?
| | Socioeconomic Factors | 2 | 2018 | 1078 | 0.220 |
Why?
| | Perioperative Care | 2 | 2015 | 127 | 0.220 |
Why?
| | Risk Factors | 5 | 2020 | 8632 | 0.210 |
Why?
| | Diabetic Ketoacidosis | 2 | 2016 | 159 | 0.200 |
Why?
| | Marketing | 2 | 2019 | 24 | 0.200 |
Why?
| | Coitus | 1 | 2002 | 27 | 0.200 |
Why?
| | Tobacco Use Disorder | 1 | 2024 | 234 | 0.200 |
Why?
| | Caregivers | 2 | 2022 | 717 | 0.190 |
Why?
| | Public Housing | 1 | 2021 | 5 | 0.190 |
Why?
| | Single-Blind Method | 1 | 2021 | 258 | 0.180 |
Why?
| | Guideline Adherence | 2 | 2015 | 490 | 0.180 |
Why?
| | Contraception | 1 | 2002 | 117 | 0.180 |
Why?
| | Intensive Care Units | 2 | 2022 | 617 | 0.180 |
Why?
| | Hospital Costs | 3 | 2016 | 104 | 0.180 |
Why?
| | Glucocorticoids | 2 | 2015 | 532 | 0.180 |
Why?
| | Prevalence | 2 | 2017 | 2251 | 0.170 |
Why?
| | Quality of Health Care | 2 | 2014 | 573 | 0.160 |
Why?
| | Health Care Costs | 1 | 2022 | 381 | 0.160 |
Why?
| | Nutrition Surveys | 1 | 2020 | 224 | 0.160 |
Why?
| | Weight Loss | 2 | 2018 | 642 | 0.160 |
Why?
| | Attitude to Health | 2 | 2017 | 406 | 0.150 |
Why?
| | Pneumonia, Viral | 2 | 2020 | 338 | 0.150 |
Why?
| | Coronavirus Infections | 2 | 2020 | 330 | 0.150 |
Why?
| | Substance Abuse Detection | 1 | 2018 | 62 | 0.150 |
Why?
| | Behavior Control | 1 | 2018 | 14 | 0.150 |
Why?
| | Odds Ratio | 2 | 2018 | 953 | 0.150 |
Why?
| | Nicotine | 2 | 2023 | 265 | 0.150 |
Why?
| | Leadership | 1 | 2021 | 292 | 0.150 |
Why?
| | Respiratory Tract Diseases | 1 | 2019 | 138 | 0.150 |
Why?
| | Workload | 1 | 2019 | 132 | 0.150 |
Why?
| | Pregnancy | 3 | 2020 | 5518 | 0.140 |
Why?
| | Journal Impact Factor | 1 | 2017 | 27 | 0.140 |
Why?
| | Prospective Studies | 4 | 2022 | 6219 | 0.140 |
Why?
| | Limit of Detection | 1 | 2016 | 53 | 0.140 |
Why?
| | Tertiary Healthcare | 1 | 2016 | 29 | 0.140 |
Why?
| | Urinalysis | 1 | 2016 | 64 | 0.130 |
Why?
| | Infant, Low Birth Weight | 1 | 2017 | 125 | 0.130 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2021 | 687 | 0.130 |
Why?
| | Health Personnel | 2 | 2017 | 574 | 0.130 |
Why?
| | Technology | 1 | 2017 | 79 | 0.130 |
Why?
| | Health Behavior | 1 | 2002 | 704 | 0.130 |
Why?
| | Video Recording | 1 | 2017 | 143 | 0.130 |
Why?
| | Herbal Medicine | 2 | 2006 | 4 | 0.130 |
Why?
| | Monitoring, Physiologic | 1 | 2018 | 249 | 0.130 |
Why?
| | Transcriptome | 1 | 2021 | 725 | 0.130 |
Why?
| | Publishing | 1 | 2017 | 124 | 0.130 |
Why?
| | Oseltamivir | 1 | 2016 | 11 | 0.130 |
Why?
| | Migraine Disorders | 1 | 2017 | 82 | 0.130 |
Why?
| | Middle Aged | 6 | 2024 | 26733 | 0.130 |
Why?
| | Respiratory Tract Infections | 1 | 2019 | 319 | 0.120 |
Why?
| | Subacute Care | 1 | 2016 | 71 | 0.120 |
Why?
| | Tobacco Industry | 1 | 2015 | 46 | 0.120 |
Why?
| | China | 1 | 2015 | 161 | 0.120 |
Why?
| | Immunization Schedule | 1 | 2016 | 184 | 0.120 |
Why?
| | Delivery of Health Care | 1 | 2002 | 833 | 0.120 |
Why?
| | Public Health | 1 | 2019 | 433 | 0.120 |
Why?
| | Tobacco, Smokeless | 1 | 2014 | 9 | 0.120 |
Why?
| | Magnesium | 1 | 2015 | 145 | 0.120 |
Why?
| | Administration, Intravenous | 1 | 2015 | 124 | 0.120 |
Why?
| | Prednisone | 1 | 2015 | 229 | 0.120 |
Why?
| | Patient Handoff | 1 | 2014 | 26 | 0.120 |
Why?
| | Periodicals as Topic | 1 | 2017 | 181 | 0.120 |
Why?
| | Steroids | 1 | 2015 | 144 | 0.120 |
Why?
| | Influenza A Virus, H1N1 Subtype | 1 | 2016 | 139 | 0.120 |
Why?
| | Nicotinic Agonists | 1 | 2015 | 100 | 0.120 |
Why?
| | Cancer Survivors | 1 | 2018 | 205 | 0.110 |
Why?
| | Depressive Disorder | 1 | 2017 | 332 | 0.110 |
Why?
| | Diagnosis, Differential | 1 | 2018 | 1342 | 0.110 |
Why?
| | Community-Acquired Infections | 1 | 2015 | 141 | 0.110 |
Why?
| | Role | 1 | 2013 | 32 | 0.110 |
Why?
| | Medical Errors | 1 | 2014 | 85 | 0.110 |
Why?
| | Patient Care | 1 | 2014 | 101 | 0.110 |
Why?
| | Continuity of Patient Care | 1 | 2016 | 253 | 0.110 |
Why?
| | Tachypnea | 1 | 2013 | 4 | 0.110 |
Why?
| | Research | 1 | 2017 | 394 | 0.110 |
Why?
| | Hospitals, Community | 1 | 2013 | 45 | 0.110 |
Why?
| | Wit and Humor as Topic | 1 | 2013 | 5 | 0.110 |
Why?
| | Tachycardia | 1 | 2013 | 50 | 0.110 |
Why?
| | Postoperative Hemorrhage | 1 | 2014 | 74 | 0.110 |
Why?
| | Benchmarking | 1 | 2014 | 161 | 0.110 |
Why?
| | Home Care Services | 1 | 2016 | 222 | 0.110 |
Why?
| | Wisconsin | 2 | 2023 | 91 | 0.110 |
Why?
| | Regression Analysis | 2 | 2016 | 944 | 0.110 |
Why?
| | Survival Rate | 1 | 2017 | 1644 | 0.100 |
Why?
| | Rural Population | 1 | 2016 | 446 | 0.100 |
Why?
| | Multivariate Analysis | 2 | 2016 | 1430 | 0.100 |
Why?
| | Interleukin-5 | 1 | 2012 | 30 | 0.100 |
Why?
| | Probability | 1 | 2013 | 289 | 0.100 |
Why?
| | Health Resources | 1 | 2013 | 122 | 0.100 |
Why?
| | Teaching Rounds | 1 | 2013 | 64 | 0.100 |
Why?
| | Efficiency | 1 | 2012 | 84 | 0.100 |
Why?
| | Depression | 1 | 2020 | 1134 | 0.100 |
Why?
| | Interleukin-4 | 1 | 2012 | 206 | 0.100 |
Why?
| | Patient Safety | 1 | 2014 | 277 | 0.090 |
Why?
| | beta Carotene | 1 | 2011 | 18 | 0.090 |
Why?
| | Treatment Outcome | 4 | 2019 | 9088 | 0.090 |
Why?
| | Quality of Life | 2 | 2019 | 2353 | 0.090 |
Why?
| | Chi-Square Distribution | 1 | 2012 | 493 | 0.090 |
Why?
| | Critical Illness | 1 | 2016 | 645 | 0.090 |
Why?
| | Practice Guidelines as Topic | 2 | 2015 | 1394 | 0.090 |
Why?
| | Health Services Accessibility | 3 | 2021 | 762 | 0.090 |
Why?
| | Academic Medical Centers | 1 | 2013 | 411 | 0.090 |
Why?
| | Comparative Effectiveness Research | 1 | 2012 | 130 | 0.090 |
Why?
| | Comorbidity | 1 | 2015 | 1448 | 0.090 |
Why?
| | Saliva | 1 | 2012 | 187 | 0.090 |
Why?
| | Antiviral Agents | 1 | 2016 | 645 | 0.090 |
Why?
| | Inflammation | 1 | 2020 | 2478 | 0.090 |
Why?
| | Folic Acid | 1 | 2011 | 161 | 0.090 |
Why?
| | Interleukin-1beta | 1 | 2012 | 370 | 0.090 |
Why?
| | Mucocutaneous Lymph Node Syndrome | 2 | 2021 | 76 | 0.090 |
Why?
| | Health Surveys | 3 | 2006 | 443 | 0.090 |
Why?
| | Vitamins | 1 | 2011 | 151 | 0.090 |
Why?
| | Insulin Resistance | 1 | 2018 | 1072 | 0.090 |
Why?
| | Outpatient Clinics, Hospital | 1 | 2010 | 79 | 0.080 |
Why?
| | Longitudinal Studies | 3 | 2024 | 2387 | 0.080 |
Why?
| | Fellowships and Scholarships | 1 | 2012 | 227 | 0.080 |
Why?
| | Analgesics, Non-Narcotic | 1 | 2011 | 120 | 0.080 |
Why?
| | Smokers | 2 | 2021 | 129 | 0.080 |
Why?
| | Neoplasms | 1 | 2023 | 2097 | 0.080 |
Why?
| | New York | 3 | 2006 | 106 | 0.080 |
Why?
| | Comprehension | 1 | 2011 | 156 | 0.080 |
Why?
| | Diabetes Mellitus | 1 | 2017 | 900 | 0.080 |
Why?
| | Communication | 1 | 2014 | 744 | 0.080 |
Why?
| | Anti-Bacterial Agents | 2 | 2015 | 1481 | 0.080 |
Why?
| | Interferon-gamma | 1 | 2012 | 719 | 0.080 |
Why?
| | Sensitivity and Specificity | 1 | 2013 | 1692 | 0.080 |
Why?
| | Hospital Mortality | 2 | 2023 | 776 | 0.080 |
Why?
| | Health Literacy | 1 | 2011 | 164 | 0.080 |
Why?
| | Logistic Models | 1 | 2013 | 1841 | 0.080 |
Why?
| | Health Care Surveys | 1 | 2010 | 539 | 0.080 |
Why?
| | Killer Cells, Natural | 2 | 2021 | 380 | 0.070 |
Why?
| | Acetaminophen | 1 | 2011 | 241 | 0.070 |
Why?
| | Betacoronavirus | 2 | 2020 | 250 | 0.070 |
Why?
| | Anxiety | 1 | 2013 | 840 | 0.070 |
Why?
| | Breast Neoplasms | 1 | 2018 | 1862 | 0.070 |
Why?
| | Magnetic Resonance Imaging | 1 | 2017 | 3046 | 0.060 |
Why?
| | Preventive Medicine | 2 | 2005 | 40 | 0.060 |
Why?
| | Brain | 1 | 2017 | 2371 | 0.060 |
Why?
| | Body Image | 1 | 2006 | 68 | 0.060 |
Why?
| | Internship and Residency | 1 | 2014 | 926 | 0.060 |
Why?
| | Mass Screening | 1 | 2012 | 1004 | 0.060 |
Why?
| | Medicare | 2 | 2022 | 665 | 0.060 |
Why?
| | Plant Extracts | 1 | 2006 | 154 | 0.060 |
Why?
| | Tomography, X-Ray Computed | 1 | 2013 | 2285 | 0.060 |
Why?
| | Diet | 1 | 2011 | 1080 | 0.060 |
Why?
| | Qualitative Research | 2 | 2021 | 934 | 0.050 |
Why?
| | Pregnancy, Unwanted | 1 | 2002 | 13 | 0.050 |
Why?
| | CD57 Antigens | 1 | 2021 | 15 | 0.050 |
Why?
| | CD56 Antigen | 1 | 2021 | 34 | 0.050 |
Why?
| | Homeless Youth | 1 | 2000 | 15 | 0.050 |
Why?
| | Chemokine CCL3 | 1 | 2020 | 15 | 0.050 |
Why?
| | Intubation, Intratracheal | 1 | 2022 | 216 | 0.040 |
Why?
| | Interleukin-17 | 1 | 2020 | 104 | 0.040 |
Why?
| | Causality | 1 | 2020 | 103 | 0.040 |
Why?
| | Intention | 1 | 2021 | 144 | 0.040 |
Why?
| | Immunity, Humoral | 1 | 2020 | 112 | 0.040 |
Why?
| | Interleukin-18 | 1 | 2020 | 219 | 0.040 |
Why?
| | Down-Regulation | 1 | 2021 | 594 | 0.040 |
Why?
| | Age Factors | 1 | 2006 | 2894 | 0.040 |
Why?
| | Canada | 1 | 2020 | 322 | 0.040 |
Why?
| | Perception | 1 | 2021 | 311 | 0.040 |
Why?
| | Hospitals | 1 | 2023 | 581 | 0.040 |
Why?
| | Family | 1 | 2022 | 589 | 0.040 |
Why?
| | Shock, Septic | 1 | 2020 | 186 | 0.040 |
Why?
| | Suicidal Ideation | 1 | 2022 | 401 | 0.040 |
Why?
| | Substance-Related Disorders | 1 | 2006 | 947 | 0.040 |
Why?
| | Pilot Projects | 1 | 2022 | 1373 | 0.040 |
Why?
| | Peer Review | 1 | 2017 | 43 | 0.040 |
Why?
| | Antibodies, Viral | 1 | 2020 | 520 | 0.040 |
Why?
| | Congresses as Topic | 1 | 2017 | 195 | 0.030 |
Why?
| | Healthcare Disparities | 1 | 2021 | 480 | 0.030 |
Why?
| | Medically Underserved Area | 1 | 2016 | 80 | 0.030 |
Why?
| | Combined Modality Therapy | 1 | 2018 | 1121 | 0.030 |
Why?
| | Drug Utilization | 1 | 2016 | 167 | 0.030 |
Why?
| | Organizational Case Studies | 1 | 2014 | 69 | 0.030 |
Why?
| | Neoplasm Staging | 1 | 2018 | 1167 | 0.030 |
Why?
| | Propensity Score | 1 | 2015 | 224 | 0.030 |
Why?
| | Birth Weight | 1 | 2017 | 440 | 0.030 |
Why?
| | Postoperative Complications | 2 | 2015 | 2128 | 0.030 |
Why?
| | Antiemetics | 1 | 2014 | 32 | 0.030 |
Why?
| | Workflow | 1 | 2014 | 133 | 0.030 |
Why?
| | Incidence | 1 | 2020 | 2313 | 0.030 |
Why?
| | Infant, Premature | 1 | 2017 | 476 | 0.030 |
Why?
| | Social Facilitation | 1 | 2013 | 10 | 0.030 |
Why?
| | Patient Acceptance of Health Care | 1 | 2019 | 681 | 0.030 |
Why?
| | Autoantibodies | 1 | 2020 | 1346 | 0.030 |
Why?
| | T-Lymphocytes | 1 | 2020 | 1737 | 0.030 |
Why?
| | Medicaid | 1 | 2016 | 406 | 0.020 |
Why?
| | Rabbits | 1 | 2013 | 733 | 0.020 |
Why?
| | Databases, Factual | 1 | 2016 | 1125 | 0.020 |
Why?
| | Chronic Disease | 1 | 2017 | 1578 | 0.020 |
Why?
| | Drug Labeling | 1 | 2011 | 42 | 0.020 |
Why?
| | Follow-Up Studies | 1 | 2018 | 4411 | 0.020 |
Why?
| | Emergency Service, Hospital | 1 | 2019 | 1815 | 0.020 |
Why?
| | Drug Therapy | 1 | 2005 | 76 | 0.020 |
Why?
| | Aged | 1 | 2022 | 19069 | 0.010 |
Why?
| | Focus Groups | 1 | 2005 | 383 | 0.010 |
Why?
| | Life Style | 1 | 2006 | 430 | 0.010 |
Why?
| | Risk-Taking | 1 | 2006 | 333 | 0.010 |
Why?
| | Age Distribution | 1 | 2000 | 342 | 0.010 |
Why?
| | Sex Distribution | 1 | 2000 | 337 | 0.010 |
Why?
| | Emergency Medical Services | 1 | 2000 | 590 | 0.010 |
Why?
| | Animals | 1 | 2013 | 31698 | 0.010 |
Why?
|
|
Wilson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|